RHY.AX · RHYTHM BIOSCIENCES LIMITED
Australia · RS rating 12 · As of 2026-10-14
| Price | 0.07 AUD |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 21 / 19 / 45 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 12 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +73.3% |
| Market cap (USD) | $18.5M |